A class of anti-inflammatory drug that blocks Cox-2 enzyme activity without impeding the activity of Cox-1. Vioxx is the best-known drug in this class, due to Merck’s withdrawal of it from the marketplace, after a possible link to cardiac episodes was uncovered.
Glossary
COX-2 Inhibitor
02.27.12
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
Carolina Medical Products Becomes CMP Pharma
Names reflects focus on niche pharmaceutical productsKristin Brooks
-
Breaking News | Promotions & Moves
-
Capsules | Trials & Filings
FDA Approves Iroko’s Zorvolex
Pain treatment uses iCeutica’s SoluMatrix Fine Particle Technology
